Based on recent headline ratings, 74% of this readership currently trusts the local media, which has an average score of 91% regionally and is currently trending positivenegative.
Media Trust Score74%

Sagimet Biosciences Announces Positive Interim Phase 2b Clinical Trial Data with …

SAN MATEO, Calif.–(BUSINESS WIRE)–Nov 3, 2022–. Sagimet Biosciences, a clinical-stage biopharmaceutical company developing novel therapeutics …

  • You already voted!
  • Read More